RVMD

Revolution Medicines, Inc.

• TipRanks·4h ago

  Analysts Conflicted on These Healthcare Names: CVS Health (CVS), Revolution Medicines (RVMD) and Neumora Therapeutics, Inc. (NMRA)

• Simply Wall St·1d ago

  Reassessing Revolution Medicines (RVMD) Valuation After Positive Phase 3 RASolute 302 Oncology Results

• Simply Wall St·3d ago

  What Revolution Medicines (RVMD)'s Phase 3 Daraxonrasib Survival Data Means For Shareholders

• NASDAQ·4d ago

  Bernstein Initiates Coverage of Revolution Medicines (RVMD) with Market Perform Recommendation

• Dow Jones·5d ago

  Revolution Medicines Initiated at Market Perform by Bernstein

• Dow Jones·5d ago

  Revolution Medicines Price Target Announced at $151.00/Share by Bernstein

• Benzinga·5d ago

  Bernstein Initiates Coverage On Revolution Medicines with Market Perform Rating, Announces Price Target of $151

• TipRanks·5d ago

  Bernstein starts Revolution Medicines at Market Perform, says upside baked in

• TipRanks·5d ago

  Revolution Medicines initiated with a Market Perform at Bernstein

• Simply Wall St·6d ago

  Revolution Medicines Recasts RAS Story With Phase 3 Win And New Firepower

• Benzinga·05/19 13:50

  GraniteShares Files High-Octane 2X ETFs Tied To Nuclear, AI, Biotech Momentum Stocks

• PUBT·05/19 05:02

  Cantargia Q1 FY26 operating loss narrows to SEK 36.9 million; net sales rise to SEK 0.5 million

• Dow Jones·05/18 16:01

  Revolution Medicines Price Target Raised to $179.00/Share From $116.00 by Truist Securities

• Dow Jones·05/18 16:01

  Revolution Medicines Coverage Assumed by Truist Securities at Buy

• Benzinga·05/18 15:51

  Truist Securities Assumes Revolution Medicines at Buy, Raises Price Target to $179